Author Archives: Isaura Santos

There are several things you can do to improve your daily routine while living with Parkinson’s. Many of these changes include small adjustments and renovations to your home, which should be your safe place now more than ever. To help you with all these overwhelming changes, we’ve put together a…

Melior Discovery, Inc. has recently announced that the United States Patent and Trademark Office (USTPO) granted the company a patent for MLR-1019, its Parkinson’s disease candidate. The patent includes the utilization of this therapeutic to address treatment for dyskinesia linked with L-DOPA therapy in Parkinson’s disease. “This recent patent award will…

Senior Helpers, one of the largest home senior care companies in the United States, recently announced it has been named the exclusive sponsor of online resources for caregiving for the Michael J. Fox Foundation for Parkinson’s Research. The Michael J. Fox Foundation is a nonprofit organization and a leading funder of Parkinson’s disease research throughout the world, committed…

The National Parkinson Foundation (NPF) recently announced that an ongoing national research project comparing telemedicine-based healthcare provided by a Parkinson’s disease center to community-based care has achieved its target of enrolling 200 participants. The 200 enrollees suffering from Parkinson’s disease will be randomly assigned to receive either their usual care or to continue treatment plus meet a Parkinson’s expert…

According to the Mayo Clinic, current treatments are often unable to address the medical needs of Parkinson’s patients, since clinicians only have access to drugs or devices that manage symptoms. Nevertheless, several developments in immunology, cell biology and other fields have advanced the potential for regenerative medicine to make an impact on treating Parkinson’s disease patients in…

Researchers from the University of Florida have uncovered a biomarker that reveals the progression of Parkinson’s disease in the brain. This finding opens a new path toward improved diagnosis and treatment of the degenerative disease. The interdisciplinary research team compared brain images of Parkinson’s patients with images belonging to a control group for…

Biotie Therapies has announced an agreement with the United States Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the company’s Phase 3 Parkinson’s disease study of tozadenant. The study (TOZ-PD) will evaluate both the safety and the efficacy of tozadenant in comparison to placebo in Parkinson’s patients currently…

The Michael J. Fox Foundation for Parkinson’s Research has announced that it is collaborating with The Edmond J. Safra Foundation to select four academic centers across the United States and one more in Canada to host the inaugural class of the Edmond J. Safra Fellowship in Movement Disorders. The five 2016-2018…

According to a recent survey, there is a need for a Parkinson’s disease organization that is committed to and focused on a grassroots voice and the consolidation of resources. In response to this, “Parkinson’s People for Awareness & Unity,” an Indiegogo campaign, was recently created to raise money…

Amarantus BioScience Holdings, a biotechnology company developing diagnostic and therapeutic products to address neurological disorders and orphan conditions, recently announced it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a United States Patent Application entitled, “Pharmacological Treatment of Parkinson’s Disease.” The patent will address intellectual property protection for eltoprazine, Amarantus’s lead…